{
  "nct_id": "NCT23959179",
  "indication": "Breast Cancer",
  "phase": "Phase 2/3",
  "sample_size": 87,
  "duration_weeks": 38,
  "dropout_rate": 0.16,
  "primary_endpoints": [
    "Overall survival"
  ],
  "secondary_endpoints": [
    "Objective response rate",
    "Overall survival"
  ],
  "blinding": "open-label",
  "control_arm": "placebo",
  "outcome_summary": "Study trial terminated early due to safety signals.",
  "success": false,
  "failure_reason": "Low compliance/adherence"
}